Home
EQH vs LIMNW Comparison

EQH vs LIMNW Comparison

Compare EQH & LIMNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EQH

LIMNW

Machine Learning Prediction

ML Decision
EQH
LIMNW

Stock Information

Founded
EQH 1859
LIMNW N/A

Country
EQH United States
LIMNW United States

Employees
EQH N/A
LIMNW N/A

Industry
EQH Specialty Insurers
LIMNW

Sector
EQH Finance
LIMNW

Exchange
EQH Nasdaq
LIMNW Nasdaq

Market Cap
EQH N/A
LIMNW N/A

IPO Year
EQH N/A
LIMNW N/A

Fundamental

Price
EQH $55.91
LIMNW $0.20

Analyst Decision
EQH Strong Buy
LIMNW

Analyst Count
EQH 11
LIMNW 0

Target Price
EQH $62.45
LIMNW N/A

AVG Volume (30 Days)
EQH 2.6M
LIMNW N/A

Earning Date
EQH 07-29-2025
LIMNW N/A

Dividend Yield
EQH 1.93%
LIMNW N/A

EPS Growth
EQH 13.70
LIMNW N/A

EPS
EQH 3.76
LIMNW N/A

Revenue
EQH $15,105,000,000.00
LIMNW N/A

Revenue This Year
EQH $22.89
LIMNW N/A

Revenue Next Year
EQH $3.86
LIMNW N/A

P/E Ratio
EQH $14.89
LIMNW N/A

Revenue Growth
EQH 45.39
LIMNW N/A

52 Week Low
EQH $36.46
LIMNW N/A

52 Week High
EQH $56.61
LIMNW N/A

Technical

Relative Strength Index (RSI)
EQH 63.19
LIMNW N/A

Support Level
EQH $53.72
LIMNW N/A

Resistance Level
EQH $54.68
LIMNW N/A

Average True Range (ATR)
EQH 1.23
LIMNW 0.00

MACD
EQH 0.14
LIMNW 0.00

Stochastic Oscillator
EQH 97.02
LIMNW 0.00

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: